Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02242058 · ClinicalTrials.gov registry record
QST-Pupillometry in Sickle Cell Disease Patients
A clinical trial, sponsored by Julia Finkel.
- Completed
- Registry status
- 96
- Enrollment target
NCT02242058 is a clinical trial that has completed, run by Julia Finkel. The registered enrollment target is 96 participants.
The verdict
NCT02242058 has completed, sponsored by Julia Finkel.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
There has been little progress for effective treatment of pain in sickle cell disease (SCD) patients. Many organizations have recognized that understanding the causes and reducing the burden of pain in SCD is critical in order to improve the quality of life in SCD patients. As patients with SCD face the challenge of living with both acute and chronic pain which is often improperly treated, our translational and interdisciplinary project aims to identify objective measures of pain sensitivity and its biochemical and genetic correlates. We hypothesize that SCD patients will have decreased tolerance to thermal and electrical stimuli.
Interventions
- OTHER Quantitative sensory testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2013-08 |
| Est. Completion | 2018-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02242058
The ClinicalTrials.gov registry entry for NCT02242058 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Julia Finkel, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quantitative sensory testing is the first listed.
NCT02242058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02242058 about?
NCT02242058 is a clinical study titled "QST-Pupillometry in Sickle Cell Disease Patients". There has been little progress for effective treatment of pain in sickle cell disease (SCD) patients. Many organizations have recognized that understanding the causes and reducing the burden of pain in SCD is critical in order to improve the quality of life in SCD patients. As patients with SCD face...
What is the current status of trial NCT02242058?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2013-08. Estimated completion is 2018-11.
What interventions are being tested in trial NCT02242058?
The interventions under investigation include: Quantitative sensory testing (OTHER).
Who is sponsoring clinical trial NCT02242058?
This trial is sponsored by Julia Finkel, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.